You are using an outdated browser. Please upgrade your browser to improve your experience.

Tbio
PLCH2
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2

Protein Summary
Description
The production of the second messenger molecules diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) is mediated by activated phosphatidylinositol-specific phospholipase C enzymes. This phospholipase activity is very sensitive to calcium. May be important for formation and maintenance of the neuronal network in the postnatal brain (By similarity). PLCH2 is a member of the PLC-eta family of the phosphoinositide-specific phospholipase C (PLC) superfamily of enzymes that cleave PtdIns(4,5) P2 to generate second messengers inositol 1,4,5-trisphosphate and diacylglycerol (Zhou et al., 2005 [PubMed 16107206]).[supplied by OMIM, Jun 2009]
Uniprot Accession IDs
Gene Name
Ensembl ID
  • ENST00000378486
  • ENSP00000367747
  • ENSG00000149527
  • ENST00000419816
  • ENSP00000389803
  • ENST00000449969
  • ENSP00000397289
  • ENST00000620687
  • ENSP00000481938
  • ENSG00000276429
  • ENST00000626246
  • ENSP00000486186
  • ENST00000627854
  • ENSP00000487140

Symbol
  • KIAA0450
  • PLCL4
  • PLCL4
  • PLC-L4
  • PLCeta2
  • PLC-eta2
Illumination Graph
Knowledge Table
Most Knowledge About
Knowledge Value (0 to 1 scale)
protein domain
1
metabolite
0.89
virus perturbation
0.68
gene perturbation
0.6
molecular function
0.6


Protein Classes
IDG Development Level Summary
Tdark

These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 18.46   (req: < 5)
Gene RIFs: 7   (req: <= 3)
Antibodies: 18   (req: <= 50)
Tbio

These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 18.46   (req: >= 5)
Gene RIFs: 7   (req: > 3)
Antibodies: 18   (req: > 50)

- OR - satisfy the following criterion:

Gene Ontology Terms: 7
Tchem

Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions

Active Ligand: 0
Tclin

Target has at least one approved drug - AND - satisfies the preceding conditions

Active Drug: 0